Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

Memorial Sloan-Kettering Cancer Center, New York

Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh

Abrams Cancer Center of the University of Pennsylvania, Philadelphia

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

Cleveland Clinic Taussig Cancer Center, Cleveland

Henry Ford Hospital, Detroit

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

UAB Comprehensive Cancer Center, Birmingham

Massachusetts General Hospital Cancer Center, Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

Wake Forest University Comprehensive Cancer Center, Winston-Salem